← All companies

CLDX

Celldex Therapeutics, Inc.

CLDX Nasdaq In Vitro & In Vivo Diagnostic Substances EDGAR ↗

$37.69

-0.80 -2.08%

Key statistics

from XBRL data in SEC filings

Market cap

$2.96B

Revenue (TTM)

$1.54M

Net income (TTM)

-$284M

EPS (TTM)

$-4.27

P/E ratio

—

Dividend yield

—

Free cash flow

-$214M

Cash

$35.7M

Total assets

$511M

Gross margin

—

52-week range

$19.72 – $40.30

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 15, 2026 8-K Director or officer change; Shareholder vote results Jun 26, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Entered a material agreement; Other events Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Results of operations (earnings release) Feb 25, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Other events Aug 19, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Director or officer change; Shareholder vote results Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Director or officer change; Shareholder vote results Jun 14, 2024 10-Q Quarter ended 2024-03-31 May 6, 2024 8-K Results of operations (earnings release) May 6, 2024 8-K Entered a material agreement; Other events Mar 1, 2024 10-K Fiscal year ended 2023-12-31 Feb 26, 2024 8-K Results of operations (earnings release) Feb 26, 2024 8-K Entered a material agreement; Other events Nov 8, 2023 8-K Other events Nov 6, 2023 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release) Nov 2, 2023 10-Q Quarter ended 2023-06-30 Aug 8, 2023 8-K Results of operations (earnings release) Aug 8, 2023 8-K Shareholder vote results Jun 15, 2023 10-Q Quarter ended 2023-03-31 May 4, 2023 8-K Results of operations (earnings release) May 4, 2023 8-K Other events Mar 22, 2023 10-K Fiscal year ended 2022-12-31 Feb 28, 2023 8-K Results of operations (earnings release) Feb 28, 2023 8-K Director or officer change; Regulation FD disclosure Feb 21, 2023